Medicare Enrolled

Dr. Edgardo Santos, MD

Hematology & Oncology · Fort Lauderdale, FL
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
500 SE 17TH ST STE 100, Fort Lauderdale, FL 33316
7543363426
Registered in NPPES since 2006
NPI: 1639260771 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Santos from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Santos? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Santos

Dr. Edgardo Santos is a hematology & oncology specialist in Fort Lauderdale, FL, with 19 years of NPI registration. Based on federal Medicare data, Dr. Santos performed 178 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Santos received a total of $1,865,832 from 109 pharmaceutical and/or device companies across 2404 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Santos is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years of NPI registration ▲ 178 Medicare services $1,865,832 industry payments

Medicare Practice Summary — 2023

Medicare Utilization ↗
178
Medicare services
Bottom 12% in FL for hematology & oncology
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
Not available
Unique patients (not deduplicated)
$43
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Blood draw (venipuncture)
Insertion of a needle into a vein to collect a blood sample.
54 $8 $10
Complete blood count (CBC) with differential
An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells.
54 $8 $34
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
29 $85 $335
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
21 $70 $237
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
20 $139 $450
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.

Industry Payment Transparency

Open Payments through 2024 ↗
$1,865,832
Total received (2018-2024)
Avg $266,547/year across 7 years
Top 0% in FL for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
109
Companies
2,404
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$214,039
2023
$418,690
2022
$359,530
2021
$248,732
2020
$142,984
2019
$255,021
2018
$226,836

Payments by company (2024)

JAZZ PHARMACEUTICALS INC.
$52,733
AstraZeneca Pharmaceuticals LP
$34,572
E.R. Squibb & Sons, L.L.C.
$26,026
PFIZER INC.
$23,577
Merck Sharp & Dohme LLC
$22,895
Regeneron Healthcare Solutions, Inc.
$19,907
Janssen Scientific Affairs, LLC
$10,868
Novocure Inc.
$6,950
Amgen Inc.
$2,750
EMD Serono, Inc.
$2,496
Boehringer Ingelheim Pharmaceuticals, Inc.
$2,258
Takeda Pharmaceuticals U.S.A., Inc.
$2,171
Daiichi Sankyo Inc.
$1,478
ABBVIE INC.
$1,413
ARRAY BIOPHARMA INC
$803
Janssen Biotech, Inc.
$580
ADC Therapeutics America, Inc.
$500
Coherus Biosciences Inc.
$369
Tempus AI, Inc
$239
Gilead Sciences, Inc.
$232
Alexion Pharmaceuticals, Inc.
$112
Bayer Healthcare Pharmaceuticals Inc.
$111
Genentech USA, Inc.
$80
GlaxoSmithKline, LLC.
$73
Amneal Pharmaceuticals LLC
$71
Novartis Pharmaceuticals Corporation
$68
Exelixis Inc.
$67
Lilly USA, LLC
$56
PharmaEssentia USA Corporation
$48
Legend Biotech USA Inc.
$39
TerSera Therapeutics LLC
$37
Pharmacosmos Therapeutics Inc.
$35
GENZYME CORPORATION
$34
SUN PHARMACEUTICAL INDUSTRIES INC.
$33
Karyopharm Therapeutics Inc.
$30
Boston Scientific Corporation
$29
Incyte Corporation
$29
Immunocore Limited
$28
Eisai Inc.
$27
Aveo Pharmaceuticals, Inc.
$25
Rigel Pharmaceuticals, Inc.
$24
Acrotech Biopharma Inc.
$21
Mirati Therapeutics, Inc.
$21
Tolmar, Inc.
$21
Myriad Genetic Laboratories, Inc.
$21
Azurity Pharmaceuticals, Inc.
$18
Fennec Pharmaceuticals, Inc.
$17
Celgene Corporation
$16
PUMA BIOTECHNOLOGY, INC.
$16
Stemline Therapeutics Inc.
$15
Top 3 companies account for 52.9% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$260,902
JAZZ PHARMACEUTICALS INC.
$192,919
Takeda Pharmaceuticals U.S.A., Inc.
$151,691
Lilly USA, LLC
$147,971
Regeneron Healthcare Solutions, Inc.
$146,841
Amgen Inc.
$112,069
Boehringer Ingelheim Pharmaceuticals, Inc.
$86,216
Genentech USA, Inc.
$85,465
Merck Sharp & Dohme Corporation
$82,093
GENZYME CORPORATION
$79,854
EMD Serono, Inc.
$70,822
E.R. Squibb & Sons, L.L.C.
$57,845
Celgene Corporation
$56,057
PFIZER INC.
$53,605
Merck Sharp & Dohme LLC
$50,276
G1 Therapeutics, Inc.
$49,254
Mirati Therapeutics, Inc.
$42,984
Dova Pharmaceuticals
$28,996
Novartis Pharmaceuticals Corporation
$22,882
Janssen Scientific Affairs, LLC
$17,795
Eli Lilly Export S.A. Puerto Rico Branch
$9,450
Novocure Inc.
$7,780
Eli Lilly and Company
$7,739
CATALYST PHARMACEUTICALS, INC.
$5,500
SANOFI-AVENTIS U.S. LLC
$4,936
Astellas Pharma US Inc
$4,771
SOBI, INC
$3,085
Pfizer Inc.
$2,525
Daiichi Sankyo Inc.
$2,507
Fujirebio Diagnostics, Incorporated
$2,258
AbbVie Inc.
$2,067
Sobi, Inc
$1,866
Janssen Biotech, Inc.
$1,659
ABBVIE INC.
$1,447
Coherus Biosciences Inc.
$1,417
Sirtex Medical Inc
$1,309
ARRAY BIOPHARMA INC
$983
NOVARTIS PHARMACEUTICALS CORPORATION
$800
ADC Therapeutics America, Inc.
$591
PFIZER ZONA FRANCA, S.A.
$535
Gilead Sciences, Inc.
$436
GlaxoSmithKline, LLC.
$383
Seagen Inc.
$260
Exelixis Inc.
$258
Tempus AI, Inc
$239
Pharmacyclics LLC, An AbbVie Company
$229
Eisai Inc.
$228
Adaptive Biotechnologies Corporation
$203
Puma Biotechnology, Inc.
$202
Incyte Corporation
$195
Bayer Healthcare Pharmaceuticals Inc.
$185
Seattle Genetics, Inc.
$164
Janssen Pharmaceuticals, Inc
$159
Karyopharm Therapeutics Inc.
$154
Ipsen Biopharmaceuticals, Inc
$149
Regeneron Pharmaceuticals, Inc.
$139
EISAI INC.
$128
Foundation Medicine, Inc.
$125
Pharmacosmos Therapeutics Inc.
$120
Alexion Pharmaceuticals, Inc.
$112
AVEO Pharmaceuticals, Inc.
$112
Kyowa Kirin, Inc.
$91
Pharmacyclics LLC, an AbbVie Company
$90
Taiho Oncology, Inc.
$88
Rigel Pharmaceuticals, Inc.
$88
TerSera Therapeutics LLC
$88
Deciphera Pharmaceuticals Inc.
$82
Bayer HealthCare Pharmaceuticals Inc.
$79
PharmaEssentia USA Corporation
$72
Amneal Pharmaceuticals LLC
$71
MorphoSys, US Inc.
$71
Boston Scientific Corporation
$55
Jazz Pharmaceuticals Inc.
$54
Blueprint Medicines Corporation
$48
TESARO, Inc.
$47
Octapharma USA, Inc.
$46
Epizyme, Inc.,
$46
Myriad Genetic Laboratories, Inc.
$43
Genentech, Inc.
$40
Legend Biotech USA Inc.
$39
BeiGene USA, Inc.
$37
Kite Pharma, Inc.
$35
PUMA BIOTECHNOLOGY, INC.
$33
SUN PHARMACEUTICAL INDUSTRIES INC.
$33
Teva Pharmaceuticals USA, Inc.
$31
Immunocore Limited
$28
Clovis Oncology, Inc.
$28
Aveo Pharmaceuticals, Inc.
$25
Servier Pharmaceuticals LLC
$24
TOLMAR Pharmaceuticals, Inc.
$23
Fortovia Therapeutics, Inc.
$23
SERVIER PHARMACEUTICALS LLC
$23
Aadi Bioscience, Inc.
$22
Acrotech Biopharma Inc.
$21
AbbVie, Inc.
$21
INSYS Therapeutics Inc
$21
Tolmar, Inc.
$21
Array BioPharma Inc.
$21
MACROGENICS, INC.
$19
TAIHO ONCOLOGY, INC.
$19
Azurity Pharmaceuticals, Inc.
$18
Organon LLC
$18
Ambu Inc.
$18
Fennec Pharmaceuticals, Inc.
$17
Agios Pharmaceuticals, Inc.
$16
Tactile Systems Technology Inc
$16
Spectrum Pharmaceuticals Inc.
$16
Stemline Therapeutics Inc.
$15
SECURA BIO, INC.
$13
Top 3 companies account for 32.5% of all-time payments
Associated products mentioned in payments ›
6 · ADCETRIS · AFINITOR · ALIMTA · ALUNBRIG · AUGTYRO · AVASTIN · Abraxane · Alecensa · Avastin · BELEODAQ · BENDEKA · BESREMI · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Bavencio · Blincyto · Braftovi · CABLIVI · CABOMETYX · CALQUENCE · CHANTIX · COPIKTRA · COSELA · CYRAMZA · Cabometyx · DARZALEX · DOPTELET · Doptelet · ELIGARD · ELITEK · ELREXFIO · ENHERTU · ENJAYMO · ERBITUX · ERLEADA · EVENITY · Enhertu · Erleada · FIRDAPSE · FLEXITOUCH · FOTIVDA · FOUNDATIONONE · FRUZAQLA · Folotyn · Fyarro · GAUCHER-DISEASE · GAVRETO · GAZYVA · GILOTRIF · Halaven · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · INREBIC · Imbruvica · In-vitro diagnostic reagents · JADENU · JAKAFI · JEMPERLI · KANJINTI · KEYTRUDA · KIMMTRAK · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LONSURF · LOQTORZI · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · MARGENZA · MEKINIST · MONJUVI · MONOFERRIC · MYLOTARG · MYRISK · NERLYNX · NINLARO · Nerlynx · Neulasta · Nplate · Nubeqa · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OJJAARA · ONTRUZANT · ONUREG · OPDIVO · OPDUALAG · Optune Lua (NovoTTF-200T) · Orserdu · PADCEV · PIQRAY · PLUVICTO · POLIVY · POTELIGEO · PROMACTA · PYRUKYND · Padcev · Pedmark · Pomalyst · Poteligeo · Prolia · QINLOCK · REBLOZYL · RETEVMO · ROZLYTREK · RYBREVANT · Revlimid · Rezlidhia · Rubraca · SARCLISA · SHINGRIX · SIR-Spheres Microspheres · SOMATULINE DEPOT · SPRYCEL · SUBSYS · SUTENT · Somatuline Depot · Stivarga · TABRECTA · TAGRISSO · TASIGNA · TAZVERIK · TECENTRIQ · TECVAYLI · TEPMETKO · THYMOGLOBULIN · TIBSOVO · TIVDAK · TUKYSA · Tarceva · Tavalisse · Tecentriq · Tepmetko · TheraSphere Y90 Glass Microspheres 10 GBq · Trodelvy · ULTOMIRIS · Udenyca · VELCADE · VENCLEXTA · VERZENIO · VIVIMUSTA · VOTRIENT · VYXEOS · Vectibix · Venclexta · Vitrakvi · XALKORI · XARELTO · XGEVA · XOSPATA · XPOVIO · XT CDX · XTANDI · Xermelo · Xospata · Xtandi · YONSA · Yescarta · ZEJULA · ZEPZELCA · ZYTIGA · Zoladex · clonoSEQ · myRisk
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a hematology & oncology specialist in Fort Lauderdale?
Compare hematology & oncology specialists in the Fort Lauderdale area by procedure volume, costs, and industry payment transparency.
Browse hematology & oncology specialists nearby

Geographic Context

Hematology & oncology specialists in nearby ZIP areas
161
County median income
$74,534
Nearest hospital to ZIP centroid (approximate)
BROWARD HEALTH MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Santos is a clinical cardiology specialist, with moderate Medicare volume, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Santos experienced with blood draw (venipuncture)?
Based on Medicare claims data, Dr. Santos performed 54 blood draw (venipuncture) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Santos receive payments from pharmaceutical companies?
Yes. Dr. Santos received a total of $1,865,832 from 109 companies across 2,404 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Santos's costs compare to other hematology & oncology specialists in Fort Lauderdale?
Dr. Santos's average Medicare payment per service is $43. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Santos) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →